Author: Mahrukh Rehan

Olema Pharmaceuticals, Inc. (OLMA) experienced an increase of 6.50% in premarket. However, the last trading session closed at $11.07 with an incline of 5.43%.

First Clinical Data on OP-1250 by OLMA – What’s it all about?

OLMA announced the first clinical data on OP-1250 in Advanced ER+ / HER2- Breast Cancer on 30^th November 2021. Firstly, OP-1250 revealed exceptionally appealing pharmacokinetics, excellent tolerability, and compelling effectiveness signs. Secondly, in a strongly pretreated patient group, robust anti-tumor activity was seen. This includes three partial responses and up to 100 percent target lesion reduction.

Thirdly, in the indicated Phase 2 dosage range, there was a 17 percent overall response rate and a 46 percent clinical benefit rate; efficacy data is still maturing, with 32 percent of patients continuing on the trial. Lastly, Phase 2 monotherapy and the first CDK4/6 inhibitor combo trials will begin in Q1 2022.

Now what?

With the expected pharmacokinetics, excellent tolerability, and early but obvious effectiveness signs, OLMA effectively met the objectives for the dose-escalation portion of the current Phase 1/2 study of OP-1250. Moreover, OLMA is particularly motivated by the reactions seen in patients who had previously received multiple lines of treatment and had ESR1 stimulatory genetic changes, illustrating that OP-1250 is an active drug.

These results give the confidence to move forward with the development program in both monotherapy and combination settings as the company works to position OP-1250 as a differentiated, potentially best-in-class CERAN that they believe could become the backbone endocrine therapy of choice for ER+ breast cancer.

Third Quarter 2021 results Revealed by OLMA

OLMA released third-quarter 2021 results on 10^th November 2021. The company had $306.0 million in cash, cash equivalents, and marketable securities. The quarter ended with a net loss of $17.7 million, compared to $7.8 million the year before. Furthermore, research and development (R&D) costs were $12.5 million, $4.7 million more than the year before. The rise in R&D spending was principally due to the progress of the ongoing Phase 1/2 clinical study of OP-1250, as well as an increase in nonclinical research activities, higher personnel-related costs, and higher non-cash stock-based compensation costs.

OP-1250 – What’s it?

OP-1250 has the ability to be a distinct, finest complete estrogen receptor (ER) antagonist (CERAN). The company looks forward to obtaining further clinical data in support of the usage of OP-1250 as a monotherapy and in combination with other authorized breast cancer therapies as OLMA recruits more individuals.

Signify Health, Inc. (SGFY) has seen an increase of 6.82% in premarket. However, the last trading session concluded at $15.25 with an incline of 5.68%.

New Service Center by SGFY – All about it

SGFY announced on 1^st December 2021 its intentions to establish a new service center in Oklahoma City. Oklahoma City joins Dallas, New York City, and Rapid City, South Dakota as the main center for on-site and remote Signify Health professionals. More than 200 job vacancies are expected to be created in the broader Oklahoma City area. And the company is currently recruiting for 50 positions that will begin in early February.

Now what?

The millions of individuals have the luxury of serving each year desire to do more in as well as around their homes to maintain their health, and those who join will be vital to making them accomplish that. Moreover, it became evident after speaking with municipal and state authorities that Oklahoma City is home to people who not only have the ideal mix of capabilities for Signify Health but also have an interest in working at purpose-driven firms.

Third Quarter 2021 Results by SGFY – What’s the update?

SGFY announced third quarter 2021 results on 10^th November 2021. Total sales for the third quarter of 2021 climbed by 29% to $199.2 million, compared to $154.7 million a year earlier. The strength in Home & Community Services propelled overall growth in the third quarter of 2021. Moreover, HCS revenue increased by 47 percent to $169.1 million in the third quarter of 2021, compared to $362 thousand in the third quarter of 2020.

So what?

The physicians, in collaboration with the coordinators, proactively meet with an increasing number of people throughout the country. This will connect and foster engagement with the wider healthcare system. This helps people to live more healthy, happy days at home. Furthermore,  SGFY generated solid financial results in the third quarter and for the nine months ended September 30, 2021, as increased customer demand for our in-home inspections fueled strong Home & Community Services revenues in the third quarter and is likely to continue into 2022.

The company continues to save money for the clients and provide excellent care to individuals. In the episodes business, the company is on target to deliver a $6 billion program size exit run rate in 2021. This will ensure a high BPCI-A program size in 2022. Lastly, SGFY is continuing to build Networks of Distinction. This will help support the potential development of non-BPCI-A episodes of the care business.

VivoPower International PLC (VVPR) saw a push of 3.22% in premarket following the announcement that the company will acquire 100% Ownership of GB Auto. However, the last trading session concluded at $3.73 with a decline of 0.27%.

Acquisition of 100% Ownership of GB Auto – What’s up?

On 7^th December 2021, VVPR announced that the company is going to acquire the ownership of GB Auto. GB Auto is a well-known leader in the supply of services, goods, and technology. Moreover, it has six branches in New South Wales, Australia, with 130 staff and a fleet of 70 cars. This includes a purpose-built electrical vehicles facility that debuted previously this year. Lastly, GB Auto’s technicians work on electric cars, auto electrical, conditioning systems, and heavy and light machinery.

UAE Expansion by VVPR – New updates

On 21^st October 2021, VVPR reported that it has expanded a subsidiary in the United Arab Emirates (UAE) as the company extends its capacities to serve the Middle East and adjacent markets. Moreover, the Company’s new subsidiary is based in the Dubai Multi Commodities Centre, the world’s finest free trade zone. The Financial Times Magazine has awarded the DMCC the Global Free Trade Zone of the Year title. It is also the Dubai government’s authority on commodities trading and business.

What’s next?

VVPR is happy to have established a foothold in the Middle East. It is the world’s largest market for Toyota Land Cruisers. The company may enhance its ability to serve this strategically important market more efficiently by expanding its physical footprint. In addition, the UAE government recently unveiled its groundbreaking Net Zero 2050 Strategic Initiative. The company would invest Dh600 billion (US$200 billion) over the next 30 years in clean and renewable energy solutions.

Apart from serving the Middle East, Dubai will also act as a vital logistical base for the African and Indian subcontinent markets. VVPR is grateful to the partners and other colleagues in Dubai who have assisted them in setting up the operations in a business-friendly way while adhering to important health and safety requirements. Last but not least, the company is excited to provide sustainable energy solutions to this significant region and to contribute to the Net Zero 2050 Strategic Initiative.

ENDRA Life Sciences Inc. (NDRA) saw a push of 6.17% in aftermarket. However, the last trading session concluded at $0.8665 with an increase of 8.31%.

VGI Health Technology Partnership with NDRA – What’s going on?

NDRA reported on 29^th November 2021 that they have signed a partnership agreement with VGI Health Technology Limited to use TAEUS technology. This technology is meant to assist patient screening and biomarker assessment in VGI’s planned Phase 2 research of IVB001. The company is looking forward to using the latest technology in the IVB001 Phase 2 trial in NAFLD-NASH.

Data on the degree of hepatic steatosis and other biomarkers collected at the start of the trial, as well as during the study, might be extremely useful in refining the understanding of systemic determinants linked to NAFLD-NASH. The company feels that TAEUS technology is specifically built to help the team with this mission. Lastly, new technologies like TAEUS can help the company run clinical trials more efficiently.

Now what?

NDRA is working with VGI on IVB001’s clinical development. End-user doctors and pharmaceutical firms pushing the NAFLD-NASH therapeutic pipeline confront the same hepatic steatosis assessment problems utilizing MRI and liver biopsy as end-user clinicians.

However, the company is offering time and cost savings through easier, quicker, and non-invasive biomarker assessments of liver fat by incorporating ENDRA’s cost-effective, non-invasive TAEUS technology into VGI’s clinical trial protocol. Last but not least, the company will grow and deepen its worldwide footprint in Australia. This will give them even more opportunities to educate care professionals and patients about the need for early identification and treatment of a disease.

Strengthening of TAEUS System

On 16^th November 2021, NDRA announced that it is working on strengthening the TAEUS system. The company speaks about the 829 patent which is for a new thermoacoustic imaging system that reduces erroneous signals. This invention allows for the reduction of radiofrequency radiation impacts on the system’s electrical components. The ‘829 patent, according to ENDRA, will cover all thermoacoustic imaging applications.

Moreover, the 848 patent covers ENDRA’s innovative phantom for use with several imaging modalities. When calibrating or verifying a thermoacoustic system for usage, this invention allows health practitioners to employ a single phantom rather than several phantoms. Lastly, as ENDRA moves forward with clinical studies in many countries, the ‘848 patent should be especially useful.

Infobird Co., Ltd (IFBD) saw a push of 11.4% in aftermarket. However, the last trading session concluded at $1.14 with a decline of 4.2%.

Intelligent interactive training product – Upgradation News

On 3^rd December 2021, IFBD announced that it has enhanced its cloud-based intelligent interactive training SaaS offering. This will enable organizations to use technologies like AI chatbots to increase the efficiency and efficacy of sales. Moreover, sales or customer support employees may train with a virtual customer at any time.

For clients with foreign training requirements, the enhanced solution now provides English training. These two tools, when used in conjunction with the company’s intelligent quality inspection solution, may establish closed-loop management of client interaction and sales or customer service agent training. In the future, this might help businesses generate even more commercial value.

What’s Next?

IFBD has a thorough grasp of companies’ sales and customer service management training issue areas as a result of many years of expertise in the customer engagement industry. When considering the high turnover rate as well as the continually updated communication scripts between representatives and consumers, the old method of training is just not as efficient.

Therefore, the company is attempting to create an innovative method for businesses to train their reps. more effectively and efficiently. The nicest feature about this training method is that you can teach as many representatives as you want to meet the same requirements. This is especially essential for foreign businesses under the effect of Covid-19. This product is well-suited to scenarios such as telemarketing sales, cloud-call center customer support, retail reception, and on-site sales training. Lastly, this solution has already piqued the curiosity of a number of businesses in the banking and retail industries.

WeChat Call Center Launch by IFBD – What’s New?

On 16^th August 2021, IFBD announced the launch of the WeChat Call Center. WeChat Call Center is a new intelligent SaaS solution that marks the Company’s debut into the sector of private domain traffic. Moreover, IFBD’s WeChat Call Center is a key component of the company’s standardized SaaS approach. It will assist businesses to increase the value of their existing clients. The Company plans to produce considerable value by creating new demand and seizing uncontested market space in a cost-effective way.

Verra Mobility Corporation (VRRM) experiences a decrease of 6.15% in aftermarket following the company’s announcement of the acquisition of T2 systems. However, the last trading session concluded at $15.45 with an incline of 0.85%.

Acquisition of T2 systems by VRRM – What’s up?

On 7^th December 2021, VRRM reported that the company has successfully acquired T2 systems. More than 1,900 institutions, municipalities, parking operators, healthcare facilities, and transportation hubs use T2 Systems’ parking software and hardware solutions. Moreover, in 2021, sales will reach about $80 million, with an adjusted EBITDA of around $21 million. Within VRRM, T2 Systems will function as a separate division. Adam Blake, the former CEO of T2 Systems, will join Verra Mobility’s executive team and report to David Roberts.

What’s Next?

Smarter, more efficient highways are needed to serve increasingly developing cities, and parking management is a key component. The range of urban transportation solutions has been expanded with this purchase. Moreover, VRRM welcomes the exceptional T2 Systems team to Verra Mobility, and the team looks forward to continuing to provide the outstanding customer service that has distinguished the T2 brand for so many years.

Third Quarter 2021 Results – What’s the update?

On 4^th November 2021, VRRM announced third quarter 2021 results. The company reported total sales of $162.1 million, 67 percent more than that of $96.9 million in the third quarter of 2020. Moreover, service revenue increased as a result of stronger travel demand, which benefited the rental vehicle sector in our Commercial Services segment. Not only this, but the net income came out to be $27.3 million and adjusted EBITDA was $82.1 million.

So what?

With overall sales of $162.1 million and considerable profit growth in both of the business sectors, the company’s team generated solid results in the third quarter. In addition, the Commercial Services business had a 75 percent growth in revenue year over year. Year over year, the Government Solutions division achieved a 61 percent rise in revenue due to improvements in both service revenue and product sales. Furthermore, VRRM made significant progress with the integration of Redflex this quarter and anticipate continuing to achieve synergies.

Second Quarter 2021 Results – How was VRRM’s quarter?

VRRM reported second-quarter 2021 results on 9^th August 2021. The company made $4.0 million in net income in the second quarter of 2021. In addition, the company generated revenue of $128.7 million in the second quarter. Not only this but the company also reported an operating cash flow of $37.5 million. Last but not least, traffic patterns strengthened throughout the quarter as local agencies relaunched their red-light and speed enforcement programs, resulting in a roughly 41% increase in service income year over year.

EPAM Systems, Inc. (EPAM) experiences an incline of 8.55% in the aftermarket because the company announced that it is going to join S&P 500 soon. However, the last trading session closed at $595 with an increase of 3.88%.

EPAM to join S&P 500 – Latest News

EPAM announced on 7^th December 2021 that it will substitute Kansas City Southern in S&P500. However, this decision will be effective from Tuesday, 14^th December.

Now what?

S&P Dow Jones Indices is the world’s leading source of index-based concepts, data, and analysis, as well as the home of well-known capital market indicators including the S&P 500 and Dow Jones Industrial Average. Items based on the indices have more assets than products depending on indices from any other source on the planet. Furthermore, S&P DJI has been creating and producing indices across a wide range of asset classes since Charles Dow established the first index in 1884, helping to define how investors evaluate and trade the markets.

Acquia Engage Award to EPAM – More About it

On 7^th December 2021, the company reported that EPAM and Mars have won the 2021 Acquia Engage Award. The Acquia Engage Awards honor elevated digital experiences built with the Acquia Open Digital Experience Platform, which includes Drupal Cloud and Marketing Cloud, by businesses all around the world. The winners show off sophisticated functionality, connectivity, efficiency, and customer experience.

Furthermore, Mars collaborated with EPAM to create a beginning kit. It is a shared toolset that gives all Mars brands a well-defined procedure and a uniform starting point for developing brand and campaign online destinations. Prior to the introduction of this platform toolkit, Mars depended on “one-off” website development services. This resulted in several discrete implementations for each specific segment or brand.

What’s Next?

EPAM happily shares this award with Mars. All the teams worked to bring to life an interface that allows the expedited development of appealing, reliable, and creating experiences at scale to match the requirements of Mars’ world-class brands by using the power of Acquia Site Factory.

LinkedIn’s Best Culture of Learning Talent Award

On 18^th November 2021, EPAM announced that it managed to win the Best culture of learning award. The award honors EPAM’s commitment to providing workers with chances for professional advancement via learning and development. Moreover, the company is happy to be recognized for its dedication to assisting the staff in developing their skills.

As a fast developing worldwide firm at the cutting edge of digital transformation solutions, the employees are critical towards success. Furthermore, EPAM helps EPAMers stay on the cutting edge of tech upskilling and soft skills development by significantly greater in the in-house learning and development (L&D) programs and the partnership with LinkedIn Learning. Lastly, this allows them to develop new skills, and generate fresh approaches to overcome clients’ most complex challenges.